Furthermore, analysis of macrophage biomarkers via IF on transplanted tumor samples in each group revealed that the M2-Exos groups had an increased percentage of F4/80+ CD206+ in contrast to the control M0-Exos groups (Fig. S1D). The gene discussed is MRC1; the disease is neoplasm.